Sign In

A subscription to JoVE is required to view this content. Sign in or start your free trial.

In This Article

  • Summary
  • Abstract
  • Introduction
  • Protocol
  • Representative Results
  • Discussion
  • Acknowledgements
  • Materials
  • References
  • Reprints and Permissions

Summary

To induce experimental autoimmune encephalomyelitis, an animal model of multiple sclerosis, mice are immunized with a water-in-oil emulsion containing an autoantigen and complete Freund's adjuvant. While several protocols exist for the preparation of these emulsions, a rapid, simple, and standardized homogenization protocol for emulsion preparation is presented here.

Abstract

Experimental autoimmune encephalomyelitis (EAE) shares similar immunological and clinical features with multiple sclerosis (MS), and is therefore widely used as a model to identify new drug targets for better patient treatment. MS is characterized by several different disease courses: relapsing-remitting MS (RRMS), primary progressive MS (PPMS), secondary progressive MS (SPMS), and a rare progressive-relapsing form of MS (PRMS). Although animal models do not accurately mimic all of these contrasting human disease phenotypes, there are EAE models that reflect some of the different clinical manifestations of MS. For example, myelin oligodendrocyte glycoprotein (MOG)-induced EAE in C57BL/6J mice mimics human PPMS, while myelin proteolipid protein (PLP)-induced EAE in SJL/J mice resembles RRMS. Other autoantigens, such as myelin basic protein (MBP), and a number of different mouse strains are also used to study EAE. To induce disease in these autoantigen-immunization EAE models, a water-in-oil emulsion is prepared and injected subcutaneously. The majority of EAE models also require an injection of pertussis toxin for the disease to develop. For consistent and reproducible EAE induction, a detailed protocol to prepare the reagents to produce antigen/adjuvant emulsions is necessary. The method described here takes advantage of a standardized method to generate water-in-oil emulsions. It is simple and fast and uses a shaking homogenizer instead of syringes to prepare quality-controlled emulsions.

Introduction

A breakdown of immunological tolerance can result in the generation of autoimmune disorders, such as multiple sclerosis (MS). It is estimated that 2.8 million people are living with MS worldwide1. Although the exact cause of MS is still largely unknown, dysregulation of autoreactive T and B cells, as well as defects in Treg function, play important roles in the pathogenesis of the disease2,3.

Animal models of autoimmune diseases are essential tools to investigate potential therapeutic modalities. The experimental autoimmune encephalomyelitis (EAE) model has b....

Protocol

All animal procedures were performed according to the practices of the Swedish Board of Animal Research and were approved by the Animal Ethics Committee, Lund-Malmö, Sweden (Permit number: M126-16).

NOTE: A schematic flow of the method is described in Figure 1.

1. Material preparation

NOTE: Prepare all the reagents aseptically in a sterile hood, and aliquot and store at the indicated tempe.......

Representative Results

The rapid, simple, and standardized protocol for the preparation of CFA/MOG emulsions is depicted in Figure 1. This method has recently been described elsewhere6. The CFA/MOG emulsions can also be prepared with other methods, such as the traditional syringe method or by vortexing. These methods were compared here by assessing the quality of the emulsions. All the methods produced water-in-oil emulsions; the homogeneity and quality of these emulsions were assessed by a.......

Discussion

Water-in-oil emulsions, such as antigen/Freund's adjuvant, have been used for more than half a century to induce EAE17. There is currently no standardized method to prepare antigen emulsions that is independent of human influence. Manual mixing using syringes is standard for most laboratories, however this method is time consuming, often results in an excessive loss of material, and the quality differs depending on the scientist preparing it.

The method presented in.......

Acknowledgements

The author would like to acknowledge the animal housing units at Lund University, Camilla Björklöv and Agnieszka Czopek, for their support, and Richard Williams, Kennedy Institute of Rheumatology, University of Oxford, UK, for constructive criticism and linguistic support producing this manuscript.

....

Materials

NameCompanyCatalog NumberComments
1 mL Injection syringeB. Braun9166017V 
1 mL Injection syringeSigma-AldrichZ683531
7 ml empty tubes with capsBertin-InstrumentsP000944LYSK0A.07 mL tube
50 mL sterile centrifuge tube Fisher Scientific1078856150 mL tube
Bordetella pertussis toxinSigma-AldrichP2980Store at -20 °C
Dispersant, light mineral oilSigma-AldrichM8410Store at RT
Emulsion kitBertin-InstrumentsD34200.10 eaContaining a tube, cap, and plunger
Incomplete Freund's AdjuvantSigma-Aldrich F5506Store at +4 °C
Mycobacterium tuberculosis, H37RAFisher ScientificDF3114-33-8Store at +4 °C
Mastersizer 2000 Malvern PanalyticalN/AParticle size analyzer
Minilys-Personal homogenizerBertin-InstrumentsP000673-MLYS0-AShaking homogenizer
MOG 35-55 Peptide   InnovagenN/A
Montanide ISA 51 VGSeppic36362ZFDA-approved oil adjuvant
Pall Acrodisc Syringe Filters 0.2 μmFisher Scientific17124381Sterlie filter
PBS, Ca2+/Mg2+ freeThermo Fisher Scientific14190144PBS
Phase-Constrast MicroscopeOlympusBX40-B
Steel Beads 3.2 mmFisher ScientificNC0445832Autoclave and store at RT
Triton X-100Sigma-Aldrich648463Store at RT

References

  1. Walton, C., et al. Rising prevalence of multiple sclerosis worldwide: Insights from the Atlas of MS, third edition. Multiple Sclerosis. 26 (14), 1816-1821 (2020).
  2. van Langelaar, J., Rijvers, L., Smolders, J., van Luijn, M. M.

Explore More Articles

Homogenization MethodAntigen adjuvant EmulsionExperimental Autoimmune EncephalomyelitisEAECFA SlurryIFA AdjuvantEmulsion PreparationAutoimmune Disease ModelCancer Vaccines

This article has been published

Video Coming Soon

JoVE Logo

Privacy

Terms of Use

Policies

Research

Education

ABOUT JoVE

Copyright © 2024 MyJoVE Corporation. All rights reserved